Alan W. Dunton, MD, Joins Rosa Board of Directors.Business Editors/Health/Medical Writers CUPERTINO, Calif.--(BUSINESS WIRE)--April 16, 2003 Rosa Pharmaceuticals, Inc., a leader in drug development risk management, today announced the election of Alan W. Dunton, MD, to its Board of Directors. "We are very excited to have Alan on the Rosa team," said Sam Holtzman, PhD, Chairman, President, and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Rosa Pharmaceuticals. "Alan Dunton is a highly experienced drug-development leader who is widely respected for his many accomplishments at Janssen and Johnson & Johnson. He brings to Rosa world-class clinical expertise and commercial perspective." Dr. Holtzman added, "Rosa centers drug development on its Predictive Risk Management(TM) methodology, which leverages the expertise of drug development leaders like Alan with rigorous quantitative methods to dramatically improve the value of pharmaceutical and biotechnology pipelines." "I'm passionate about Rosa," said Dr. Dunton, "both as a company and as a force for change in the industry." Dr. Dunton is a pharmaceutical/biotechnology executive and a recognized leader in drug development and clinical research. He was recently named President and Chief Executive Officer of MetaPhore Pharmaceuticals, Inc. His twenty years TWENTY YEARS. The lapse of twenty years raises a presumption of certain facts, and after such a time, the party against whom the presumption has been raised, will be required to prove a negative to establish his rights. 2. of experience includes appointments as President and Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of Emisphere Technologies, Inc., President and Managing Director of the Janssen Research Foundation, a Johnson & Johnson company, and executive positions at Roche, CIBA-GEIGY (now Novartis), and Syntex. He completed his postgraduate postgraduate after first degree graduation, the registerable degree in veterinary science. postgraduate degree may be a research degree, e.g. PhD, or a course-work masterate with a vocational bias, or any combination of these. training at the New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the Medical Center/Bellevue Hospital VA Medical Center and held a Fellowship in Clinical Pharmacology Clinical pharmacology is the science of drugs and their clinical use. It is underpinned by the basic science of pharmacology, with added focus on the application of pharmacological principles and methods in the real world. at Cornell University/Medical College/New York Hospital. Rosa Pharmaceuticals is a drug development company that provides strategic risk management and drug development services to pharmaceutical and biotechnology firms. Rosa's unique Predictive Risk Management(TM) methodology integrates scientific, clinical, financial, and marketing expertise with powerful quantitative methods to optimize and realize the value of drug development pipelines. Rosa services include trial design and optimization, dose-response simulation, patient-variability analysis, strategic program planning, licensing due-diligence, dynamic market analysis, and pipeline prioritization. Rosa also provides oversight and execution services at all stages of drug development, from preclinical studies preclinical studies, n.pl a term used to describe research done before a clinical study. May be laboratory or epidemiologic research. and proof-of-concept trials to late clinical phases. Rosa professionals have successfully advised most of the world's largest pharmaceutical firms and dozens of mid-sized and emerging pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. . The company is headquartered in Cupertino, California. More information is available at http://www.rosapharma.com. Statements in this release that are not strictly historical are "forward looking" statements as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Actual events may differ materially from those projected in forward looking statements due to uncertainties in the company's operations, development efforts, and business environment. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion